Studies on human bile. V. Influence of cholestyramine treatment on the composition of bile in healthy subjects.
D000328:Adult; D001646:Bile / Q000032:analysis*; D001647:Bile Acids and Salts / Q000032:analysis*; D001835:Body Weight; D002766:Cholecystokinin / Q000008:administration & dosage; D002784:Cholesterol / Q000032:analysis / Q000097:blood; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000494:pharmacology*; D004386:Duodenum; D005260:Female; D005998:Glycine / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D008297:Male; D010758:Phosphorus / Q000032:analysis; D012995:Solubility; D013654:Taurine / Q000032:analysis; D013997:Time Factors
D001647:Bile Acids and Salts; D002792:Cholestyramine Resin; D013654:Taurine; D010758:Phosphorus; D002766:Cholecystokinin; D002784:Cholesterol; D005998:Glycine